1 Answer
Ranbaxy, an India-based pharmaceutical company, agreed to delay release of its generic version of Lipitor until Nov. 30.
According to its website, Ranbaxy will have the exclusive right to sell its drug in the U.S. for six months.
Experts say when generic versions of these drugs make it to market, pharmaceutical companies could face billions in potential losses, while consumers could save tens of billions of dollars a year.
13 years ago. Rating: 0 | |
Top contributors in Uncategorized category
Unanswered Questions
Masori Oficial
Answers: 0
Views: 8
Rating: 0
qq88milano
Answers: 0
Views: 7
Rating: 0
qq88milano
Answers: 0
Views: 4
Rating: 0
xoilactvnvn.cc Scamming users
Answers: 0
Views: 12
Rating: 0
Restaurant in Jaipur
Answers: 0
Views: 10
Rating: 0
Xocdia88
Answers: 0
Views: 9
Rating: 0
188BET - Trang Chủ 188BET Chính Thức Đăng Ký Mới Nhất 2025
Answers: 0
Views: 8
Rating: 0
188BET - Trang Chủ 188BET Chính Thức Đăng Ký Mới Nhất 2025
> More questions...
Answers: 0
Views: 8
Rating: 0